EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN

The effect of piperidine and related alicyclic amines on central nicotinic and muscarinic cholinoceptors was investigated by measuring specific binding of [3H] nicotine and [3H] cismethyldioxolane (CD) in rat cerebral cortical membranes. Piperidine, pyrrolidine, 4-hydroxypiperidine and piperazine at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Pharmacobio-Dynamics 1986, Vol.9(7), pp.620-625
Hauptverfasser: YAMADA, SHIZUO, KAGAWA, YOSHIYUKI, USHIJIMA, HIDETO, TAKAYANAGI, NORIYASU, HAYASHI, EIICHI
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 625
container_issue 7
container_start_page 620
container_title Journal of Pharmacobio-Dynamics
container_volume 9
creator YAMADA, SHIZUO
KAGAWA, YOSHIYUKI
USHIJIMA, HIDETO
TAKAYANAGI, NORIYASU
HAYASHI, EIICHI
description The effect of piperidine and related alicyclic amines on central nicotinic and muscarinic cholinoceptors was investigated by measuring specific binding of [3H] nicotine and [3H] cismethyldioxolane (CD) in rat cerebral cortical membranes. Piperidine, pyrrolidine, 4-hydroxypiperidine and piperazine at concentrations of 1μM-30 mM completed dosedependently with [3H] nicotine and [3H] CD for the binding sites. Among these compounds, piperidine was the most potent competitor of brain [3H] nicotine binding sites. Piperidine and pyrrolidine showed a greater affinity for [3H] nicotine binding sites in the rat cerebral cortex than of [3H] CD binding sites. In contrast, 4-hydroxypiperidine and piperazine displayed approximately 10 times greater affinity for [3H] CD binding sites. Pipecolic acid had little effect on these cholinoceptor agonist binding sites. The inhibitory effect of brain [3H] nicotine binding by piperidine did not differ between brain regions or during development. In addition, there was little difference in the piperidine-induced inhibition of brain [3H] nicotine binding between species such as rat, mouse, guinea-pig and rabbit. Thus, the present study demonstrates a high affinity of piperidine for nicotinic cholinoceptors in the mammalian brain.
doi_str_mv 10.1248/bpb1978.9.620
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77120455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77120455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-665159841574d7a60bbd39b114dc577799185d409ad9535c935884e828b8cf7a3</originalsourceid><addsrcrecordid>eNpNkM2P0zAQxS0EWsrCkSOSD4hbih3HsX30pmnXUuOs2qwEJ8txXOgq_SBuD_DX49Ko4uCxPO83b-QHwEeMpjjN-Nf22GLB-FRM8xS9AhPMOU4woeQ1mCDC84Rn-be34F0ILwhlglN8B-4IYynDfAL-lPN5WTSwnsMn9VSu1EzpEko9g6tyKZtyBuVSFd-LWKCsoraGtYZaFXWj9KUXyep5XcjV9bmotVo38EHpaLSAa9XECaVh81jCSlZVdJMaPqyk0u_Bm43tg_8w3vfgeV42xWOyrBeqkMvEUYZPSZ5TTAXPMGVZx2yO2rYjosU46yLAmBCY0y5DwnaCEuoEoZxnnqe85W7DLLkHX66-x-Hw6-zDyey2wfm-t3t_OAfDGE5RRmkEkyvohkMIg9-Y47Dd2eG3wchcsjZj1kaYmHXkP43G53bnuxs9hhv1z6Nug7P9ZrB7tw03jMcfofSCySv2Ek72h7_pdjhtXe__W8r-nbj6prmfdjB-T_4CFP2SHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77120455</pqid></control><display><type>article</type><title>EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>YAMADA, SHIZUO ; KAGAWA, YOSHIYUKI ; USHIJIMA, HIDETO ; TAKAYANAGI, NORIYASU ; HAYASHI, EIICHI</creator><creatorcontrib>YAMADA, SHIZUO ; KAGAWA, YOSHIYUKI ; USHIJIMA, HIDETO ; TAKAYANAGI, NORIYASU ; HAYASHI, EIICHI</creatorcontrib><description>The effect of piperidine and related alicyclic amines on central nicotinic and muscarinic cholinoceptors was investigated by measuring specific binding of [3H] nicotine and [3H] cismethyldioxolane (CD) in rat cerebral cortical membranes. Piperidine, pyrrolidine, 4-hydroxypiperidine and piperazine at concentrations of 1μM-30 mM completed dosedependently with [3H] nicotine and [3H] CD for the binding sites. Among these compounds, piperidine was the most potent competitor of brain [3H] nicotine binding sites. Piperidine and pyrrolidine showed a greater affinity for [3H] nicotine binding sites in the rat cerebral cortex than of [3H] CD binding sites. In contrast, 4-hydroxypiperidine and piperazine displayed approximately 10 times greater affinity for [3H] CD binding sites. Pipecolic acid had little effect on these cholinoceptor agonist binding sites. The inhibitory effect of brain [3H] nicotine binding by piperidine did not differ between brain regions or during development. In addition, there was little difference in the piperidine-induced inhibition of brain [3H] nicotine binding between species such as rat, mouse, guinea-pig and rabbit. Thus, the present study demonstrates a high affinity of piperidine for nicotinic cholinoceptors in the mammalian brain.</description><identifier>ISSN: 0386-846X</identifier><identifier>EISSN: 1881-1353</identifier><identifier>DOI: 10.1248/bpb1978.9.620</identifier><identifier>PMID: 3772718</identifier><identifier>CODEN: JOPHDQ</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>[3H] nicotine ; Amines - pharmacology ; Animals ; Animals, Newborn ; Binding, Competitive - drug effects ; Biological and medical sciences ; Brain - metabolism ; Guinea Pigs ; In Vitro Techniques ; Medical sciences ; Mice ; Nicotine - metabolism ; Parasympathomimetics - pharmacology ; Pharmacology. Drug treatments ; Piperidines - pharmacology ; Rabbits ; Rats ; Rats, Inbred Strains ; Receptors, Muscarinic - drug effects ; Receptors, Nicotinic - drug effects ; Species Specificity</subject><ispartof>Journal of Pharmacobio-Dynamics, 1986, Vol.9(7), pp.620-625</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1987 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-665159841574d7a60bbd39b114dc577799185d409ad9535c935884e828b8cf7a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8157028$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3772718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YAMADA, SHIZUO</creatorcontrib><creatorcontrib>KAGAWA, YOSHIYUKI</creatorcontrib><creatorcontrib>USHIJIMA, HIDETO</creatorcontrib><creatorcontrib>TAKAYANAGI, NORIYASU</creatorcontrib><creatorcontrib>HAYASHI, EIICHI</creatorcontrib><title>EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN</title><title>Journal of Pharmacobio-Dynamics</title><addtitle>Journal of Pharmacobio-Dynamics</addtitle><description>The effect of piperidine and related alicyclic amines on central nicotinic and muscarinic cholinoceptors was investigated by measuring specific binding of [3H] nicotine and [3H] cismethyldioxolane (CD) in rat cerebral cortical membranes. Piperidine, pyrrolidine, 4-hydroxypiperidine and piperazine at concentrations of 1μM-30 mM completed dosedependently with [3H] nicotine and [3H] CD for the binding sites. Among these compounds, piperidine was the most potent competitor of brain [3H] nicotine binding sites. Piperidine and pyrrolidine showed a greater affinity for [3H] nicotine binding sites in the rat cerebral cortex than of [3H] CD binding sites. In contrast, 4-hydroxypiperidine and piperazine displayed approximately 10 times greater affinity for [3H] CD binding sites. Pipecolic acid had little effect on these cholinoceptor agonist binding sites. The inhibitory effect of brain [3H] nicotine binding by piperidine did not differ between brain regions or during development. In addition, there was little difference in the piperidine-induced inhibition of brain [3H] nicotine binding between species such as rat, mouse, guinea-pig and rabbit. Thus, the present study demonstrates a high affinity of piperidine for nicotinic cholinoceptors in the mammalian brain.</description><subject>[3H] nicotine</subject><subject>Amines - pharmacology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Guinea Pigs</subject><subject>In Vitro Techniques</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Nicotine - metabolism</subject><subject>Parasympathomimetics - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - pharmacology</subject><subject>Rabbits</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Receptors, Muscarinic - drug effects</subject><subject>Receptors, Nicotinic - drug effects</subject><subject>Species Specificity</subject><issn>0386-846X</issn><issn>1881-1353</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkM2P0zAQxS0EWsrCkSOSD4hbih3HsX30pmnXUuOs2qwEJ8txXOgq_SBuD_DX49Ko4uCxPO83b-QHwEeMpjjN-Nf22GLB-FRM8xS9AhPMOU4woeQ1mCDC84Rn-be34F0ILwhlglN8B-4IYynDfAL-lPN5WTSwnsMn9VSu1EzpEko9g6tyKZtyBuVSFd-LWKCsoraGtYZaFXWj9KUXyep5XcjV9bmotVo38EHpaLSAa9XECaVh81jCSlZVdJMaPqyk0u_Bm43tg_8w3vfgeV42xWOyrBeqkMvEUYZPSZ5TTAXPMGVZx2yO2rYjosU46yLAmBCY0y5DwnaCEuoEoZxnnqe85W7DLLkHX66-x-Hw6-zDyey2wfm-t3t_OAfDGE5RRmkEkyvohkMIg9-Y47Dd2eG3wchcsjZj1kaYmHXkP43G53bnuxs9hhv1z6Nug7P9ZrB7tw03jMcfofSCySv2Ek72h7_pdjhtXe__W8r-nbj6prmfdjB-T_4CFP2SHg</recordid><startdate>1986</startdate><enddate>1986</enddate><creator>YAMADA, SHIZUO</creator><creator>KAGAWA, YOSHIYUKI</creator><creator>USHIJIMA, HIDETO</creator><creator>TAKAYANAGI, NORIYASU</creator><creator>HAYASHI, EIICHI</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1986</creationdate><title>EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN</title><author>YAMADA, SHIZUO ; KAGAWA, YOSHIYUKI ; USHIJIMA, HIDETO ; TAKAYANAGI, NORIYASU ; HAYASHI, EIICHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-665159841574d7a60bbd39b114dc577799185d409ad9535c935884e828b8cf7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>[3H] nicotine</topic><topic>Amines - pharmacology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Guinea Pigs</topic><topic>In Vitro Techniques</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Nicotine - metabolism</topic><topic>Parasympathomimetics - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - pharmacology</topic><topic>Rabbits</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Receptors, Muscarinic - drug effects</topic><topic>Receptors, Nicotinic - drug effects</topic><topic>Species Specificity</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMADA, SHIZUO</creatorcontrib><creatorcontrib>KAGAWA, YOSHIYUKI</creatorcontrib><creatorcontrib>USHIJIMA, HIDETO</creatorcontrib><creatorcontrib>TAKAYANAGI, NORIYASU</creatorcontrib><creatorcontrib>HAYASHI, EIICHI</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Pharmacobio-Dynamics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YAMADA, SHIZUO</au><au>KAGAWA, YOSHIYUKI</au><au>USHIJIMA, HIDETO</au><au>TAKAYANAGI, NORIYASU</au><au>HAYASHI, EIICHI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN</atitle><jtitle>Journal of Pharmacobio-Dynamics</jtitle><addtitle>Journal of Pharmacobio-Dynamics</addtitle><date>1986</date><risdate>1986</risdate><volume>9</volume><issue>7</issue><spage>620</spage><epage>625</epage><pages>620-625</pages><issn>0386-846X</issn><eissn>1881-1353</eissn><coden>JOPHDQ</coden><abstract>The effect of piperidine and related alicyclic amines on central nicotinic and muscarinic cholinoceptors was investigated by measuring specific binding of [3H] nicotine and [3H] cismethyldioxolane (CD) in rat cerebral cortical membranes. Piperidine, pyrrolidine, 4-hydroxypiperidine and piperazine at concentrations of 1μM-30 mM completed dosedependently with [3H] nicotine and [3H] CD for the binding sites. Among these compounds, piperidine was the most potent competitor of brain [3H] nicotine binding sites. Piperidine and pyrrolidine showed a greater affinity for [3H] nicotine binding sites in the rat cerebral cortex than of [3H] CD binding sites. In contrast, 4-hydroxypiperidine and piperazine displayed approximately 10 times greater affinity for [3H] CD binding sites. Pipecolic acid had little effect on these cholinoceptor agonist binding sites. The inhibitory effect of brain [3H] nicotine binding by piperidine did not differ between brain regions or during development. In addition, there was little difference in the piperidine-induced inhibition of brain [3H] nicotine binding between species such as rat, mouse, guinea-pig and rabbit. Thus, the present study demonstrates a high affinity of piperidine for nicotinic cholinoceptors in the mammalian brain.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>3772718</pmid><doi>10.1248/bpb1978.9.620</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0386-846X
ispartof Journal of Pharmacobio-Dynamics, 1986, Vol.9(7), pp.620-625
issn 0386-846X
1881-1353
language eng
recordid cdi_proquest_miscellaneous_77120455
source J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects [3H] nicotine
Amines - pharmacology
Animals
Animals, Newborn
Binding, Competitive - drug effects
Biological and medical sciences
Brain - metabolism
Guinea Pigs
In Vitro Techniques
Medical sciences
Mice
Nicotine - metabolism
Parasympathomimetics - pharmacology
Pharmacology. Drug treatments
Piperidines - pharmacology
Rabbits
Rats
Rats, Inbred Strains
Receptors, Muscarinic - drug effects
Receptors, Nicotinic - drug effects
Species Specificity
title EFFECT OF PIPERIDINE AND RELATED ALICYCLIC AMINES ON NICOTINIC AND MUSCARINIC AGONIST BINDING SITES IN THE MAMMALIAN BRAIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A28%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFECT%20OF%20PIPERIDINE%20AND%20RELATED%20ALICYCLIC%20AMINES%20ON%20NICOTINIC%20AND%20MUSCARINIC%20AGONIST%20BINDING%20SITES%20IN%20THE%20MAMMALIAN%20BRAIN&rft.jtitle=Journal%20of%20Pharmacobio-Dynamics&rft.au=YAMADA,%20SHIZUO&rft.date=1986&rft.volume=9&rft.issue=7&rft.spage=620&rft.epage=625&rft.pages=620-625&rft.issn=0386-846X&rft.eissn=1881-1353&rft.coden=JOPHDQ&rft_id=info:doi/10.1248/bpb1978.9.620&rft_dat=%3Cproquest_cross%3E77120455%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77120455&rft_id=info:pmid/3772718&rfr_iscdi=true